NHS
UK Provides £1.4M in Funding for Two-Year Study on Genedrive Test to Prevent Newborn Hearing Loss
The Manchester University NHS Foundation Trust will study across the UK the use of Genedrive's MT-RNR1 ID Kit as a pharmacogenomic test to prevent hearing loss.
BMJ Report Reveals UK Officials' Concerns Over Grail Test Effectiveness, Trial Design
The report also mentions a US investor class action lawsuit that alleges Illumina and Grail officials oversold Galleri's potential.
The agency also recently published a statement regarding pathways for tests cleared in the US, Canada, EU, and Australia to be more quickly placed on the UK market.
UK NHS Declines to Accelerate Grail Galleri Implementation Following Early Data Review
The decision comes just weeks after Grail officials touted the decision as a potential positive catalyst for the firm as it prepares to be divested by Illumina.
UK's NICE Expands Tumor Profiling Recommendations for Guiding Adjuvant Chemo in Early Breast Cancer
Previously, NICE recommended EndoPredict, Prosigna, and Oncotype DX for node-negative breast cancer only, but the new guidance includes lymph node-positive disease.